ASAM Home Page

Education

The ASAM Board Exam Study Course

July 16-17, 2020 - The essential primer for physicians and other healthcare professionals who are preparing for a career in addiction medicine, and for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.
Education

Treatment of Opioid Use Disorder Course

July 14, 2020 - Cover treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM offers this 8-hour course in a blended format combining live and online learning.
Education

Moving Beyond the Barriers of Treating OUD

July 15, 2020 - Provides a deeper dive into implementing office-based treatment for opioid use disorder. This case-based interactive 2.5-hour course addresses moving beyond common barriers that prevent DEA-waivered clinicians from successfully treating patients with OUD.

COVID-19 Coronavirus

Guidance, resources, and news from around the country regarding addiction treatment in the wake of COVID-19.

The ASAM Criteria

The nation’s most widely used and comprehensive set of guidelines for placement, continued stay, and transfer/discharge of patients with addiction and co-occurring conditions.

Advocacy News May 12, 2020

House Democrats Introduce The Heroes Act: A New Legislative Package to Respond to COVID-19 Pandemic

House Democrats introduced the Heroes Act, the fourth legislative package designed to address the COVID-19 pandemic.
Full story
Advocacy News May 11, 2020

ASAM Applauds Introduction of the Health Care at Home Act

The Mental Health Liaison Group (MHLG) sent a letter commending the introduction of H.R. 6644, the Health Care at Home Act, which would require group health plans and health insurers to cover telehealth services during the COVID-19 public health emergency.
Full story

News April 28, 2020

American Society of Addiction Medicine Announces New EVP/CEO

ASAM proudly announces the appointment of Julia L. Chang, MBA, MS as the organization’s new EVP/CEO beginning May 27, 2020. She will succeed Penny S. Mills, MBA who is retiring after 10 years of dedicated and transformative leadership to ASAM.
Full story
News March 20, 2020

Amidst COVID-19 Crisis, ASAM Releases Updated National Practice Guideline for Treating Opioid Use Disorder

ASAM developed the National Practice Guideline to provide information on evidence-based treatment of opioid use disorder, and is the first to address all of the FDA-approved medications available to treat addiction involving opioid use and opioid overdose in a single document.
Full story